Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
暂无分享,去创建一个
Javier Martín | M. González-Gay | G. Espinosa | M. Vonk | P. Carreira | G. Riemekasten | T. Radstake | T. Krieg | L. Beretta | B. Koeleman | A. Schuerwegh | T. Witte | N. Hunzelmann | A. Voskuyl | C. Simeón | P. Airó | J. Distler | A. Kreuter | C. Lunardi | M. Camps | M. Teruel | J. Broen | M. Gallego | R. García-Portales | E. Delgado-Frías
[1] Jane Worthington,et al. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations. , 2012, Human molecular genetics.
[2] L. Bossini-Castillo,et al. Unraveling the genetic component of systemic sclerosis , 2012, Human Genetics.
[3] Raphael Zidovetzki,et al. A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap , 2011, PLoS genetics.
[4] P. Gregersen,et al. Genomics and the multifactorial nature of human autoimmune disease. , 2011, The New England journal of medicine.
[5] R. Toes,et al. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis , 2011, Annals of the rheumatic diseases.
[6] Annette Lee,et al. Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy , 2011, PLoS genetics.
[7] Javier Martín,et al. Influence of CD40 rs1883832 Polymorphism in Susceptibility to and Clinical Manifestations of Biopsy-proven Giant Cell Arteritis , 2010, The Journal of Rheumatology.
[8] Luis Rodrigo,et al. CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility , 2010, PloS one.
[9] Annette Lee,et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus , 2010, Nature Genetics.
[10] G. Bishop,et al. CD40 and autoimmunity: the dark side of a great activator. , 2009, Seminars in immunology.
[11] Pablo Moscato,et al. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.
[12] R. Noelle,et al. Molecular mechanism and function of CD40/CD40L engagement in the immune system , 2009, Immunological reviews.
[13] Jing Cui,et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis , 2008, Nature Genetics.
[14] C. Erausquin,et al. Association of the microsatellite in the 3' untranslated region of the CD154 gene with rheumatoid arthritis in females from a Spanish cohort: a case-control study , 2007, Arthritis research & therapy.
[15] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[16] M. Fujimoto,et al. Increased serum soluble CD40 levels in patients with systemic sclerosis. , 2007, The Journal of rheumatology.
[17] A. Siegbahn,et al. Soluble CD40L Levels Are Regulated by the −3459 A>G Polymorphism and Predict Myocardial Infarction and the Efficacy of Antithrombotic Treatment in Non-ST Elevation Acute Coronary Syndrome , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[18] C. Langefeld,et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). , 2006, American heart journal.
[19] G. Abecasis,et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies , 2006, Nature Genetics.
[20] Taiji Oashi,et al. A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. , 2005, Endocrinology.
[21] M. Daly,et al. Haplotype structure of TNFRSF5-TNFSF5 (CD40–CD40L) and association analysis in systemic lupus erythematosus , 2005, European Journal of Human Genetics.
[22] V. Lougaris,et al. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features , 2005, Immunological reviews.
[23] D. Borderie,et al. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers , 2004, Annals of the rheumatic diseases.
[24] C. Rodríguez-Gallego,et al. The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus , 2004, Annals of the rheumatic diseases.
[25] N. Kamatani,et al. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40‐CD154 in the phenotype of SSc fibroblasts , 2003, European journal of immunology.
[26] T. Kipps,et al. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. , 2001, The Journal of rheumatology.
[27] T. Medsger,et al. Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.
[28] R. Vakkalanka,et al. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. , 1999, Arthritis and rheumatism.
[29] M. Béné,et al. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. , 1997, Clinical immunology and immunopathology.
[30] T. Medsger,et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.
[31] M. Kozak. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.
[32] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[33] James F. Fries,et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.